SUMMARY Type I collagen is a heteropolymer of al(I) and a2(I) chains, each of which is a separate product of genes localised to chromosomes 17 and 7 respectively. Molecular defects of type I collagen produce a group of inherited disorders of connective tissue primarily affecting bones, which are easily broken and collagen depleted (osteogenesis imperfecta 
All have a regular order and gross structural similarities sharing C and N terminal non-helical extensions which have inter-and intra-chain disulphide bonds. These regions are excised by specific N and C terminal peptidases before the head to toe assembly of individual collagen triple helices to form the final mature collagen fibrils." These then pack in a characteristic one-quarter staggered pattern, which appears in longitudinal section as a regular banded cross striation.
Intermolecular cross linking occurs between specific overlapping peptide regions of the interstitial molecules, and mutations of this region could certainly produce significant disease, as could abnormalities within the procollagen extension peptides which contain globular non-helical and helical sequences at the N terminus and non-helical extensions at the C terminus. The C propeptide also contains an asparagine residue which is later mannosylated. The extension peptides are crucial to secretion of the proteins and their correct assembly into the final mature fibrils.
The amino sequence of these proteins is highly conserved and is really a repeating polymer of general formula (Gly XY)303 where X and Y are often proline and lysine respectively. These latter residues are usually hydroxylated by specific proline and lysine hydroxylases and this stabilises the triple helix which would otherwise melt below normal body temperatures. Other modifications include an excess of hydrophobic side chains (a2(I), (al(IV), and a l(V) chains) and cysteine residues"1 which form and stabilise interchain disulphide bands in al(III) and al(IV) chains. Presumably these modifications stabilise and strengthen the collagen triple helix and have been highly conserved in evolution. Conversely, point mutations or other structural alterations produce instability of these regions and also very probably specific human diseases.
Collagen genes
The rapid advances in human recombinant DNA technology in the past five or six years has allowed the cloning and sequencing of numerous collagen and other structural genes. cDNA clones from collagen mRNA enabled al(I) and a2(I) collagen genes from sheep and chick to be quickly isolated. '2 13 As expected, these have non-coding introns separating the coding exons and the chicken a2 gene proves to have more than 50 introns with exon sizes which are always multiples of nine base pairs, the most common being 54 This disease presented as a series of badly healed fractures to the left tibia of a 9 year old male ( fig 5) . He fractured his right tibia quite justifiably from a fall from a climbing frame but subsequently had broken his left tibia which then repeatedly fractured through the union. Eventually, healing was achieved only by rodding of the affected bone.27 At this operation the surgeon noted that the abnormal bone was unusually hard but also brittle. We were provided with bone and skin biopsies from which we successfully cultured skin and periosteal fibroblasts.
Using radiolabelled 14C glycine and proline we then examined the cultured collagens by column chromatography and polyacrylamide gel electrophoresis (figs 6 and 7a, b). His mother, who had premature lumbar spinal osteoporosis (fig Sc) and a history of childhood fractures of small hand bones, was also studied. Column chromatography of pepsinised radiolabelled collagens showed an unexpected shoulder in the position of al(I) collagen. Polyacrylamide slab gel electrophoresis showed an extra disulphide linked dimer in addition to normal al(I), which could be reduced to monomeric form by mercaptoethanol (fig 7a) . This was clearly separate from al(III) collagen, which is normally disulphide linked, in contrast to normal al(I) collagen, which never is. Then (fig 13a, b) . The MspI polymorphism at the opposite end of the gene normally generates a 2*1 kb fragment, which in the presence of an added site becomes 1*6 and 0*5, giving 2-1, 1-6, and 0-5 kb fragments in heterozygotes; this has also been described by others.55 The allelic frequencies are EcoRI (no site) 68%, MspI (no site) 14%. Both Other polymorphisms of the same gene have also been described, namely a HindIII and a PvuII polymorphism, within the 9-3 EcoRI fragment 3-8 kb 5' to the Eco7 4.3 kb fragment described above. Using the 9*2 kb Eco fragment as a probe, PvuII digestion detects a 3*3 kb fragment in those lacking an extra site and a 1-7 and 1 6 kb fragment when an extra site is present. The HindIII variable site lies 1.5 kb 3' of the PvuII variable site. Sykes and his colleagues63 have recently failed to show segregation of this marker with Sillence type I 01, suggesting that the cartilage gene cannot therefore be involved in the aetiology of this 01 variant. Provided there is no intragenic recombination within the remaining 18 kb of the gene, this conclusion seems valid. 
